These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells. Gallwitz B, Schmidt WE, Conlon JM, Creutzfeldt W. J Mol Endocrinol; 1990 Aug; 5(1):33-9. PubMed ID: 2168708 [Abstract] [Full Text] [Related]
8. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. Volz A, Göke R, Lankat-Buttgereit B, Fehmann HC, Bode HP, Göke B. FEBS Lett; 1995 Oct 02; 373(1):23-9. PubMed ID: 7589426 [Abstract] [Full Text] [Related]
9. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin. Gault VA, O'Harte FP, Harriott P, Mooney MH, Green BD, Flatt PR. Diabetologia; 2003 Feb 02; 46(2):222-30. PubMed ID: 12627321 [Abstract] [Full Text] [Related]
11. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. Oben J, Morgan L, Fletcher J, Marks V. J Endocrinol; 1991 Aug 02; 130(2):267-72. PubMed ID: 1919397 [Abstract] [Full Text] [Related]
16. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas. Suzuki S, Kawai K, Ohashi S, Watanabe Y, Yamashita K. Metabolism; 1992 Apr 19; 41(4):359-63. PubMed ID: 1556941 [Abstract] [Full Text] [Related]